tadalafil has been researched along with tryptoline in 2 studies
Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (tryptoline) | Trials (tryptoline) | Recent Studies (post-2010) (tryptoline) |
---|---|---|---|---|---|
1,742 | 392 | 1,089 | 222 | 1 | 69 |
Protein | Taxonomy | tadalafil (IC50) | tryptoline (IC50) |
---|---|---|---|
Vif | Human immunodeficiency virus 1 | 84.25 | |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 84.25 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bischoff-Kont, I; Chaikuad, A; Faudone, G; Fürst, R; Heering, J; Kaiser, A; Knapp, S; Merk, D; Rachor, L; Willems, S; Zhubi, R | 1 |
Abadi, AH; Ahmed, NS; Gary, BD; Laufer, S; Piazza, GA; Tinsley, HN | 1 |
2 other study(ies) available for tadalafil and tryptoline
Article | Year |
---|---|
Propranolol Activates the Orphan Nuclear Receptor TLX to Counteract Proliferation and Migration of Glioblastoma Cells.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Glioblastoma; HEK293 Cells; Humans; Molecular Structure; Orphan Nuclear Receptors; Propranolol; Receptors, Cytoplasmic and Nuclear; Structure-Activity Relationship | 2021 |
Design, synthesis and structure-activity relationship of functionalized tetrahydro-β-carboline derivatives as novel PDE5 inhibitors.
Topics: Carbolines; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Design; Humans; Inhibitory Concentration 50; Phosphodiesterase 5 Inhibitors; Structure-Activity Relationship; Tadalafil | 2011 |